Ndufaf6 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
.infobox .infobox-protein
{
float: right;
width: 300px;
padding: 10px;
background: #f8f9fa;
border: 1px solid #ddd;
border-radius: 4px;
margin: 10px;
}
.infobox .infobox-protein th
{
background: #28a745;
color: white;
padding: 8px;
}
.infobox .infobox-protein td
{
padding: 6px;
}
NDUFAF6 Protein (NDUFAF6) is a protein involved in cellular signaling and molecular processes. It is expressed in various tissues including the brain and plays roles in neuronal function and disease mechanisms.
NDUFAF6 contains an N-terminal Fe-S cluster-binding domain and a C-terminal domain of unknown function. It interacts with other assembly factors and subunits of complex I.
NDUFAF6 is an assembly factor for mitochondrial complex I (NADH:ubiquinone oxidoreductase). It is required for the proper assembly and stability of complex I. Complex I is the largest enzyme of the mitochondrial electron transport chain.
NDUFAF6 mutations cause mitochondrial complex I deficiency, which presents with Leigh syndrome and other encephalomyopathies. Complex I deficiency is a hallmark of PD, where there is selective loss of complex I activity in the substantia nigra.
No specific therapies exist for NDUFAF6-related disorders. CoQ10 and L-carnitine supplementation may support mitochondrial function. Gene therapy is in development. Complex I-targeted compounds are being explored for PD.
The study of Ndufaf6 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.